APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Prevention and Treatment Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tuberculosis Prevention and Treatment Vaccine Industry Research Report 2026

2 January 2026122 pages

Choose your research edition.

Industry ResearchTuberculosis Prevention and Treatment Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Prevention and Treatment Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tuberculosis Prevention and Treatment Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Prevention and Treatment Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Prevention and Treatment Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Tuberculosis Prevention and Treatment Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tuberculosis Prevention and Treatment Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tuberculosis Prevention and Treatment Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Prevention and Treatment Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tuberculosis Prevention and Treatment Vaccine include Merck, Taj Pharmaceuticals, Serum Institute of India, Queen Saovabha Mem. Inst, Microgen, Japan BCG Lab, IVAC, GreenSignal Bio Pharma and China National Biotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tuberculosis Prevention and Treatment Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tuberculosis Prevention and Treatment Vaccine Market by Company

Merck

Taj Pharmaceuticals

Serum Institute of India

Queen Saovabha Mem. Inst

Microgen

Japan BCG Lab

IVAC

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

BioFarma

Ataulpho de Paiva

AJ Vaccines

Tuberculosis Prevention and Treatment Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Prevention and Treatment Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Prevention and Treatment Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Prevention and Treatment Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Prevention and Treatment Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Prevention and Treatment Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tuberculosis Prevention and Treatment Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tuberculosis Prevention and Treatment Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tuberculosis Prevention and Treatment Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tuberculosis Prevention and Treatment Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tuberculosis Prevention and Treatment Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tuberculosis Prevention and Treatment Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Tuberculosis Prevention and Treatment Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Product Type & Application Table 14. Global Tuberculosis Prevention and Treatment Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tuberculosis Prevention and Treatment Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 22. Merck Recent Developments Table 23. Taj Pharmaceuticals Company Information Table 24. Taj Pharmaceuticals Business Overview Table 25. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 27. Taj Pharmaceuticals Recent Developments Table 28. Serum Institute of India Company Information Table 29. Serum Institute of India Business Overview Table 30. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 32. Serum Institute of India Recent Developments Table 33. Queen Saovabha Mem. Inst Company Information Table 34. Queen Saovabha Mem. Inst Business Overview Table 35. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 37. Queen Saovabha Mem. Inst Recent Developments Table 38. Microgen Company Information Table 39. Microgen Business Overview Table 40. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 42. Microgen Recent Developments Table 43. Japan BCG Lab Company Information Table 44. Japan BCG Lab Business Overview Table 45. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 47. Japan BCG Lab Recent Developments Table 48. IVAC Company Information Table 49. IVAC Business Overview Table 50. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 52. IVAC Recent Developments Table 53. GreenSignal Bio Pharma Company Information Table 54. GreenSignal Bio Pharma Business Overview Table 55. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 57. GreenSignal Bio Pharma Recent Developments Table 58. China National Biotec Company Information Table 59. China National Biotec Business Overview Table 60. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 62. China National Biotec Recent Developments Table 63. Biomed Lublin Company Information Table 64. Biomed Lublin Business Overview Table 65. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 67. Biomed Lublin Recent Developments Table 68. BioFarma Company Information Table 69. BioFarma Business Overview Table 70. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 72. BioFarma Recent Developments Table 73. Ataulpho de Paiva Company Information Table 74. Ataulpho de Paiva Business Overview Table 75. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 77. Ataulpho de Paiva Recent Developments Table 78. AJ Vaccines Company Information Table 79. AJ Vaccines Business Overview Table 80. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolio Table 82. AJ Vaccines Recent Developments Table 83. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021-2026) & (K Units) Table 85. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2021-2026) Table 86. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2027-2032) & (K Units) Table 87. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2027-2032) Table 88. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2021-2026) Table 90. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2027-2032) Table 92. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units) Table 94. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2027-2032) & (K Units) Table 95. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units) Table 99. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2027-2032) & (K Units) Table 100. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units) Table 109. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2027-2032) & (K Units) Table 110. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units) Table 118. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2027-2032) & (K Units) Table 119. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2021-2026) Table 120. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2027-2032) Table 121. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2021-2026) Table 124. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2027-2032) Table 125. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2021-2026) & (US$/Unit) Table 126. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2027-2032) & (US$/Unit) Table 127. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units) Table 128. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2027-2032) & (K Units) Table 129. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2021-2026) Table 130. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2027-2032) Table 131. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2021-2026) Table 134. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2027-2032) Table 135. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2021-2026) & (US$/Unit) Table 136. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Tuberculosis Prevention and Treatment Vaccine Distributors List Table 140. Tuberculosis Prevention and Treatment Vaccine Customers List Table 141. Tuberculosis Prevention and Treatment Vaccine Industry Trends Table 142. Tuberculosis Prevention and Treatment Vaccine Industry Drivers Table 143. Tuberculosis Prevention and Treatment Vaccine Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tuberculosis Prevention and Treatment Vaccine Product Image Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tuberculosis Prevention and Treatment Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Tuberculosis Prevention and Treatment Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Immune Vaccine Product Image Figure 10. Therapy Vaccine Product Image Figure 11. Self-Procurement Product Image Figure 12. UNICEF Product Image Figure 13. Other Product Image Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Tuberculosis Prevention and Treatment Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region in 2025 Figure 20. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region in 2025 Figure 21. North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2025 Figure 22. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2025 Figure 27. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2025 Figure 35. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2021-2032) Figure 37. China Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2025 Figure 46. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2021-2032) Figure 47. South America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2021-2032) Figure 48. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country in 2025 Figure 52. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Tuberculosis Prevention and Treatment Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2021-2032) Figure 58. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2021-2032) Figure 59. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Type (2021-2032) Figure 60. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2021-2032) Figure 61. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2021-2032) Figure 62. Global Tuberculosis Prevention and Treatment Vaccine Price (US$/Unit) by Application (2021-2032) Figure 63. Tuberculosis Prevention and Treatment Vaccine Value Chain Figure 64. Tuberculosis Prevention and Treatment Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Tuberculosis Prevention and Treatment Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • Merck
  • Taj Pharmaceuticals
  • Serum Institute of India
  • Queen Saovabha Mem. Inst
  • Microgen
  • Japan BCG Lab
  • IVAC
  • GreenSignal Bio Pharma
  • China National Biotec
  • Biomed Lublin
  • BioFarma
  • Ataulpho de Paiva
  • AJ Vaccines

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales (2021-2032)
  5. 2.2.3 Global Tuberculosis Prevention and Treatment Vaccine Market Average Price (2021-2032)
  6. 2.3 Tuberculosis Prevention and Treatment Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Immune Vaccine
  9. 2.3.3 Therapy Vaccine
  10. 2.4 Tuberculosis Prevention and Treatment Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Self-Procurement
  13. 2.4.3 UNICEF
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tuberculosis Prevention and Treatment Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tuberculosis Prevention and Treatment Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tuberculosis Prevention and Treatment Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Tuberculosis Prevention and Treatment Vaccine, Established Date
  9. 3.9 Global Tuberculosis Prevention and Treatment Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Taj Pharmaceuticals
  8. 4.2.1 Taj Pharmaceuticals Company Information
  9. 4.2.2 Taj Pharmaceuticals Business Overview
  10. 4.2.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  12. 4.2.5 Taj Pharmaceuticals Recent Developments
  13. 4.3 Serum Institute of India
  14. 4.3.1 Serum Institute of India Company Information
  15. 4.3.2 Serum Institute of India Business Overview
  16. 4.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  18. 4.3.5 Serum Institute of India Recent Developments
  19. 4.4 Queen Saovabha Mem. Inst
  20. 4.4.1 Queen Saovabha Mem. Inst Company Information
  21. 4.4.2 Queen Saovabha Mem. Inst Business Overview
  22. 4.4.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  24. 4.4.5 Queen Saovabha Mem. Inst Recent Developments
  25. 4.5 Microgen
  26. 4.5.1 Microgen Company Information
  27. 4.5.2 Microgen Business Overview
  28. 4.5.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Microgen Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  30. 4.5.5 Microgen Recent Developments
  31. 4.6 Japan BCG Lab
  32. 4.6.1 Japan BCG Lab Company Information
  33. 4.6.2 Japan BCG Lab Business Overview
  34. 4.6.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  36. 4.6.5 Japan BCG Lab Recent Developments
  37. 4.7 IVAC
  38. 4.7.1 IVAC Company Information
  39. 4.7.2 IVAC Business Overview
  40. 4.7.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 IVAC Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  42. 4.7.5 IVAC Recent Developments
  43. 4.8 GreenSignal Bio Pharma
  44. 4.8.1 GreenSignal Bio Pharma Company Information
  45. 4.8.2 GreenSignal Bio Pharma Business Overview
  46. 4.8.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  48. 4.8.5 GreenSignal Bio Pharma Recent Developments
  49. 4.9 China National Biotec
  50. 4.9.1 China National Biotec Company Information
  51. 4.9.2 China National Biotec Business Overview
  52. 4.9.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  54. 4.9.5 China National Biotec Recent Developments
  55. 4.10 Biomed Lublin
  56. 4.10.1 Biomed Lublin Company Information
  57. 4.10.2 Biomed Lublin Business Overview
  58. 4.10.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  60. 4.10.5 Biomed Lublin Recent Developments
  61. 4.11 BioFarma
  62. 4.11.1 BioFarma Company Information
  63. 4.11.2 BioFarma Business Overview
  64. 4.11.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  66. 4.11.5 BioFarma Recent Developments
  67. 4.12 Ataulpho de Paiva
  68. 4.12.1 Ataulpho de Paiva Company Information
  69. 4.12.2 Ataulpho de Paiva Business Overview
  70. 4.12.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  72. 4.12.5 Ataulpho de Paiva Recent Developments
  73. 4.13 AJ Vaccines
  74. 4.13.1 AJ Vaccines Company Information
  75. 4.13.2 AJ Vaccines Business Overview
  76. 4.13.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Portfolio
  78. 4.13.5 AJ Vaccines Recent Developments
5 Global Tuberculosis Prevention and Treatment Vaccine Market Scenario by Region
  1. 5.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tuberculosis Prevention and Treatment Vaccine Value Chain Analysis
  2. 8.1.1 Tuberculosis Prevention and Treatment Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tuberculosis Prevention and Treatment Vaccine Production Mode & Process
  5. 8.2 Tuberculosis Prevention and Treatment Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tuberculosis Prevention and Treatment Vaccine Distributors
  8. 8.2.3 Tuberculosis Prevention and Treatment Vaccine Customers
9 Global Tuberculosis Prevention and Treatment Vaccine Analyzing Market Dynamics
  1. 9.1 Tuberculosis Prevention and Treatment Vaccine Industry Trends
  2. 9.2 Tuberculosis Prevention and Treatment Vaccine Industry Drivers
  3. 9.3 Tuberculosis Prevention and Treatment Vaccine Industry Opportunities and Challenges
  4. 9.4 Tuberculosis Prevention and Treatment Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst